Effect of human interleukin-10 on the expression of nitric oxide synthases in the MPTP-based model of Parkinson's disease

Pharmacological Reports

Volumn 65, Issue 1, 2013, Pages 44-49

  Schwenkgrub, Joanna ^a   Joniec Maciejak, Ilona ^a   Sznejder Pachołek, Anna ^a   Wawer, Adriana ^a   Ciesielska, Agnieszka ^c   Bankiewicz, Krzysztof ^c   Członkowska, Anna ^a,b   Członkowski, Andrzej ^a  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

^b INSTITUTE OF PSYCHIATRY AND NEUROLOGY   (Poland)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

IL 10; INOS; MPTP; Nitric oxide synthase; NNOS; Parkinson's disease; Viral vector

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; DOPAMINE; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 10; NEURONAL NITRIC OXIDE SYNTHASE; PARVOVIRUS VECTOR; TYROSINE 3 MONOOXYGENASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN DAMAGE; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINERGIC NERVE CELL; DRUG MECHANISM; ENZYME DEFICIENCY; ENZYME REGULATION; GENE EXPRESSION REGULATION; GENE THERAPY; GLIA; MALE; MOUSE; NERVE CELL DEGENERATION; NERVE STIMULATION; NEUROPROTECTION; NONHUMAN; PARKINSON DISEASE; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; UPREGULATION;

EID: 84875795989     PISSN: 22995684     EISSN: 22995684     Source Type: Journal    
DOI: 10.1016/s1734-1140(13)70962-9     Document Type: Article

References (29)

1. Aquilano K, Baldelli S, Rotilio G, Ciriolo MR: Role of nitric oxide synthases in Parkinson's disease: A review on the antioxidant and anti-inflammatory activity of polyphenols. Neurochem Res, 2008, 33, 2416-2426.
2. Arimoto T, Choi DY, Lu X, Liu M, Nguyen XV, Zheng N, Stewart CA et al.: Interleukin-10 protects against inflammation-mediated degeneration of dopaminergic neurons in substantia nigra. Neurobiol Aging, 2007, 28, 894-906.
3. Brown GC: Nitric oxide and neuronal death. Nitric Oxide, 2010, 23, 153-165.
4. Ciesielska A, Joniec I, Kurkowska-Jastrzebska I, Cudna A, Przybyłkowski A, Członkowska A, Członkowski A: The impact of age and gender on the striatal astrocytes activation in murine model of Parkinson's disease. Inflamm Res, 2009, 58, 747-753.
5. Dehmer T, Lindenau J, Haid S, Dichgans J, Schulz JB: Deficiency of inducible nitric oxide synthase protects against MPTP toxicity in vivo. J Neurochem, 2000, 74, 2213-2216.
6. Di Filippo M, Chiasserini D, Tozzi A, Picconi B, Calabresi P: Mitochondria and the link between neuroinflammation and neurodegeneration. J Alzheimers Dis, 2010, 20, 369-379.
7. Eriksen JL,Wszolek Z, Petrucelli L:Molecular pathogenesis of Parkinson disease. Arch Neurol, 2005, 62, 353-357.
8. Ferrante RJ, Hantraye P, Brouillet E, Beal MF: Increased nitrotyrosine immunoreactivity in substantia nigra neurons in MPTP treated baboons is blocked by inhibition of neuronal nitric oxide synthase. Brain Res, 1999, 823, 177-182.
9. Forster C, Clark HB, Ross ME, Iadecola C: Inducible nitric oxide synthase expression in human cerebral infarcts. Acta Neuropathol, 1999, 97, 215-220.
10. Hirsch EC, Hunot S: Neuroinflammation in Parkinson's disease: a target for neuroprotection? Lancet Neurol, 2009, 8, 382-397.
11. Johnston LC, Su X, Maguire-Zeiss K, Horovitz K, Ankoudinova I, Guschin D, Hadaczek P et al.: Human interleukin-10 gene transfer is protective in a rat model of Parkinson's disease. Mol Ther, 2008, 16, 1392-1399.
12. Joniec I, Ciesielska A, Kurkowska-Jastrzebska I, Przybylkowski A, Czlonkowska A, Czlonkowski A: Ageand sex-differences in the nitric oxide synthase expression and dopamine concentration in the murine model of Parkinson's disease induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Brain Res, 2009, 1261, 7-19.
13. Kavya R, Saluja R, Singh S, Dikshit M: Nitric oxide synthase regulation and diversity: Implications in Parkinson's disease. Nitric Oxide, 2006, 15, 280-284.
14. Kowalczyk E, Kopff A, Kopff M, Błaszczyk J, Fijałkowski P, Kowalski J: Metabolism of nitric oxide (Polish). Wiad Lek, 2006, 59, 889-893.
15. Kuter K, Kolasiewicz W, Gołembiowska K, Dziubina A, Schulze G, Berghauzen K, Wardas J, Ossowska K: Partial lesion of the dopaminergic innervation of the ventral striatum induces "depressive-like" behavior of rats. Pharmacol Rep, 2011, 63, 1383-1392.
16. Lees AJ, Hardy J, Revesz T: Parkinson's disease. Lancet, 2009, 373, 2055-2066.
17. Lewandowicz AM, Pawliczak R: Arginine metabolism in bronchial asthma. (Polish). Postepy Hig Med Dosw, 2007, 61, 156-166.
18. Liu B, Hong JS: Role of microglia in inflammation-mediated neurodegenerative diseases: Mechanisms and strategies for therapeutic intervention. J Pharmacol Exp Ther, 2003, 304, 1-7.
19. Lüth H, Münch G, Arendt T: Aberrant expression of NOS isoforms in Alzheimer's disease is structurally related to nitrotyrosine formation. Brain Res, 2002, 953, 135-143.
20. Mariotto S, Suzuki Y, Persichini T, ColasantiM, Suzuki H, Cantoni O: Cross-talk between NO and arachidonic acid in inflammation. CurrMed Chem, 2007, 14, 1940-1944.
21. Miller RL, James-Kracke M, Sun GY, Sun AY: Oxidative and inflammatory pathways in Parkinson's disease. Neurochem Res, 2009, 34, 55-65.
22. Molina-Holgado E, Arévalo-Martín A, Castrillo A, Boscá L, Vela JM, Guaza C: Interleukin-4 and interleukin-10 modulate nuclear factor kB activity and nitric oxide synthase-2 expression in Theiler's virusinfected brain astrocytes. J Neurochem, 2002, 81, 1242-1252.
23. Muramatsu Y, Kurosaki R, Watanabe H, Michimata M, Matsubara M, Imai Y, Araki T: Cerebral alterations in a MPTP-mouse model of Parkinson's disease - an immunocytochemical study. J Neural Transm, 2003, 110, 1129-114.
24. Paxinos G, Franklin KBJ: The Mouse Brain in Stereotaxic Coordinates. Academic Press, San Diego CA, 2001.
25. Singha S, Dikshit M: Apoptotic neuronal death in Parkinson's disease: Involvement of nitric oxide. Brain Res Rev, 2007, 54, 233-250.
26. Teismann P, Schulz JB: Cellular pathology of Parkinson's disease: astrocytes, microglia and inflammation. Cell Tissue Res, 2004, 318, 149-161.
27. Toulouse A, Sullivan AM: Progress in Parkinson's disease - where do we stand? Prog Neurobiol, 2008, 85, 376-392.
28. Yokoyama H, Kuroiwa H, Yano R, Araki T: Targeting reactive oxygen species, reactive nitrogen species and inflammation in MPTP neurotoxicity and Parkinson's disease. Neurol Sci, 2008, 29, 293-301.
29. Zhou L, Zhu D: Neuronal nitric oxide synthase: structure, subcellular localization, regulation, and clinical implications. Nitric Oxide, 2009, 20, 223-230.